Snowball logo
logo
9009

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B

900904 SHG
$0.472+$0.02  (4.42%)
Estimate
P/E
47.2
EPS
0.01
Beta
0.367
Growth
Revenue, YoY
-7.84%
Net income, YoY
13.28%
FCF, YoY
454.21%
About the company
Ticker
900904
ISIN
CNE0000003X8
Country
China
Sector (GICS)
Healthcare
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin injection, loquat cough granules, strong loquat dew, loquat cough capsules, jinwu gutong capsules, coral ringworm net, jingwu capsules, quantianma capsules, yindan xintai pills, etc. The company was founded in 1990 and is based in Shanghai, China.

Frequently asked questions

What sector does Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) operate in?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) current stock price?

As of the latest data, Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B stock price is $0.47, with a previous close of $0.45. Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B gained $0.02 in the last trading session, representing a 4.42% increase.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) current market capitalization?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B market cap is approximately 25.84 million.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) Earnings Per Share (EPS)?

The trailing EPS is $0.01.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) Price-to-Earnings (P/E) ratio?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B current P/E ratio is 47.2.

Does Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) pay dividends?

No. Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B does not pay a dividend.

What is Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B (900904) beta (volatility) score?

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B has a beta of 0.367, indicating lower volatility than the overall market.